Oncologic Emergencies and Immunotherapy-Related Toxicities

Kristin Youngblood, PharmD

Schedule:       May 20, 2021

                        Live Virtual Session – 12 noon and again at 3pm, Bangor ME

Audience:       Accredited for Pharmacists and Technicians

                        Other interested health care professionals welcome

Credits:          1 Contact Hour of Knowledge-based

                        1.0 CEUs will be awarded under the provider                                                             

Presenter(s):    Kristin Youngblood, PharmD, Clinical Pharmacist of Oncology, Northern Light Eastern Maine Medical Center

No charge for CE

Learning Objectives for Pharmacists:


After attending this program, participants will be able to:

  1. Describe the appropriate treatment of hypercalcemia of malignancy based on severity
  2. Identify patients who are at risk of developing tumor lysis syndrome
  3. Outline a prevention strategy for tumor lysis syndrome
  4. Recognize the appropriate management of immunotherapy-related colitis based on severity

Learning Objectives for Technicians:


  1. Recall how to calculate corrected calcium
  2. List risk factors for developing tumor lysis syndrome
  3. Describe the role of corticosteroids for the treatment of immunotherapy-related toxicities

This website uses cookies to understand how you use the website and to improve your experience. By continuing to use the website, you accept the University of New England’s use of cookies and similar technologies. To learn more about our use of cookies and how to manage your browser cookie settings, please review our Privacy Notice.